首页> 外文期刊>Journal of Medicinal Chemistry >Design and synthesis of substrate and intermediate analogue inhibitors of S-ribosylhomocysteinase
【24h】

Design and synthesis of substrate and intermediate analogue inhibitors of S-ribosylhomocysteinase

机译:S-核糖基同型半胱氨酸酶底物和中间体类似物抑制剂的设计与合成

获取原文
获取原文并翻译 | 示例
       

摘要

S-Ribosylhomocysteinase (LuxS) catalyzes the cleavage of the thioether linkage in S-ribosylhomocysteine (SRH) to produce homocysteine and 4,5-dihydroxy-2,3-pentanedione, the precursor of autoinducer 2. Inhibitors of LuxS should interfere with bacterial interspecies communication and potentially provide a novel class of antibacterial agents. LuxS utilizes a divalent metal ion as a Lewis acid during catalysis. In this work, a series of structural analogues of the substrate SRH and a 2-ketone intermediate were designed and synthesized. Kinetic studies indicate that the compounds act as reversible, competitive inhibitors against LuxS, with the most potent inhibitors having K-I values in the submicromolar range. These represent the most potent LuxS inhibitors that have been reported to date. Cocrystal structures of LuxS bound with two of the inhibitors largely confirmed the design principles, i.e., the importance of both the homocysteine and ribose moieties in high-affinity binding to the LuxS active site.
机译:S-核糖基同型半胱氨酸酶(LuxS)催化S-核糖基同型半胱氨酸(SRH)中硫醚键的裂解,产生高半胱氨酸和4,5-二羟基-2,3-戊二酮,自动诱导剂2的前体。交流,并可能提供一类新型的抗菌剂。 LuxS在催化过程中利用二价金属离子作为路易斯酸。在这项工作中,设计并合成了底物SRH和2-酮中间体的一系列结构类似物。动力学研究表明,该化合物可作为可逆的,竞争性的LuxS抑制剂,其中最有效的抑制剂的K-1值在亚微摩尔范围内。这些代表了迄今为止已报道的最有效的LuxS抑制剂。与两种抑制剂结合的LuxS的共晶体结构在很大程度上证实了设计原理,即同型半胱氨酸和核糖部分在与LuxS活性位点的高亲和力结合中的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号